New Draft Regulatory Guidance Would Speed Breast Cancer Drug Approval

The Foundation for the National Institutes of Health announced the release of a draft guidance by the Food and Drug Administration on a new breast cancer drug trial design.

Advertisement

The new approach would reduce the time and cost of bringing new treatments to patients.

Click here to read the full story in Becker’s Hospital Review on the FDA.

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.